Metropolitan Life Insurance Company (MetLife)’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-223
Closed -$8.98K 2373
2022
Q2
$8.98K Buy
+223
New +$16.3K ﹤0.01% 2320

Other funds holding SNCE

Metropolitan Life Insurance Company (MetLife)'s SNCE Position: Q3 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Science 37 Holdings, Inc. Common Stock (SNCE) in Q3 2022, closing a stake of 223 shares — an estimated $8.98K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in SNCE in Q2 2022 and held it in 1 quarter. The position peaked at $8.98K in Q2 2022. 68 funds tracked by Wall St. Rank hold SNCE as of Q3 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Science 37 Holdings, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 223 Science 37 Holdings, Inc. Common Stock shares in Q3 2022, an estimated $8.98K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Science 37 Holdings, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Metropolitan Life Insurance Company (MetLife)'s Science 37 Holdings, Inc. Common Stock position peaked at $8.98K in Q2 2022.
  • 68 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q3 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2022, filed 14 Nov 2022.